Drug Type Autologous CAR-T |
Synonyms Autologous PSMA-specific chimeric antigen cells co-expressing LIGHT |
Target |
Action modulators |
Mechanism PSMA modulators(Prostate-specific membrane antigen modulators), T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseSuspendedPhase 1 |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Castration-Resistant Prostatic Cancer | Phase 1 | China | 16 Jul 2020 |





